Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to ...
A cellular resistance mechanism at the origin of relapses of triple-negative breast cancer has recently been discovered by ...
Last November, Marcela Tinka received devastating news: she was diagnosed with triple-negative breast cancer, a fast-moving form that affects about 10% to 15% of breast cancer patients.
Our experts agree that there are many simple ways to minimize the chances of breast cancer returning. Adopting a healthy ...
Daiichi Sankyo Company ((DSKYF)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...
Pink Alliance's 22nd annual 'Surviving and Thriving' Luncheon is an event that raises vital funds for local breast cancer ...
Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis ...
A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.
The team, led by oncologist Dr. Angela DeMichele, has advanced a method to identify and attack these dormant cells. Called ...
A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.
The breakthrough gives new options for patients whose cancers no longer respond to existing therapies. The post New antibody ...
A newly developed antibody that restricts the growth of treatment-resistant breast cancers offers new hope for patients. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results